Citius Oncology, Inc.
CTOR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851484
No open-market purchases or sales by Citius Oncology, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.20M in total; no superinvestor holds it.
Holders of 5% or more of CTOR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Citius Oncology, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. | 13D/A | 77.90%66.0M shares | −1.20 ppfrom 79.10% | Jul 25, 20253 filings | Dec 17, 2025 | SEC |
| Armistice Capital, LLC | 13G | 9.79%7.68M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Citius Oncology, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 17, 20254:10 PM ET | Citius Pharmaceuticals, Inc. | 13D/A | 77.90%66.0M shares | −1.20 ppfrom 79.10% | Dec 10, 2025 | SEC |
| Nov 14, 20256:41 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.79%7.68M shares | New | Sep 30, 2025 | SEC |
| Sep 12, 20254:15 PM ET | Citius Pharmaceuticals, Inc. | 13D/A | 79.10%66.0M shares | −5.20 ppfrom 84.30% | Sep 10, 2025 | SEC |
| Jul 25, 20255:00 PM ET | Citius Pharmaceuticals, Inc. | 13D/A | 84.30%66.0M shares | – | Jul 17, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Citius Oncology, Inc. shares.
No Form 144 notices for Citius Oncology, Inc. are on file.